DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/45r6bs/rheumatoid) has announced the addition of the "Rheumatoid Arthritis - Pipeline Review, H2 2014" report to their offering.
This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Rheumatoid Arthritis Overview
- Therapeutics Development
- Rheumatoid Arthritis - Therapeutics under Development by Companies
- Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes
- Rheumatoid Arthritis - Pipeline Products Glance
- Rheumatoid Arthritis - Products under Development by Companies
- Rheumatoid Arthritis - Products under Investigation by Universities/Institutes
- Rheumatoid Arthritis - Companies Involved in Therapeutics Development
- Rheumatoid Arthritis - Therapeutics Assessment
- Drug Profiles
- Rheumatoid Arthritis - Recent Pipeline Updates
- Rheumatoid Arthritis - Dormant Projects
- Rheumatoid Arthritis - Discontinued Products
- Rheumatoid Arthritis - Product Development Milestones
For more information visit http://www.researchandmarkets.com/research/45r6bs/rheumatoid